|
|
|
Scientific
Publications - Work Done by Microbiology Reader Free Online Full-text Article J. Biol. Chem., Vol. 278, Issue 12, 10264-10272, March 21, 2003 Ser3p ( Yer081wp ) and Ser33p ( Yil074cp ) Are Phosphoglycerate Dehydrogenases in Saccharomyces cerevisiae*
|
| |
ABSTRACT |
|---|
Two genes YER081W and YIL074C, renamed SER3 and SER33,
respectively, which encode phosphoglycerate dehydrogenases in Saccharomyces
cerevisiae were identified. These dehydrogenases catalyze the
first reaction of serine and glycine biosynthesis from the glycolytic
metabolite 3-phosphoglycerate. Unlike either single mutant, the
ser3
ser33
double mutant lacks detectable phosphoglycerate dehydrogenase
activity and is auxotrophic for serine or glycine for growth on
glucose media. However, the requirement for the SER-dependent
"phosphoglycerate pathway" is conditional since the "glyoxylate"
route of serine/glycine biosynthesis is glucose-repressed. Thus, in
cells grown on ethanol both expression and activity of all SER-encoded
proteins are low, including the remaining enzymes of the
phosphoglycerate pathway, Ser1p and Ser2p. Moreover the available
nitrogen source regulates the expression of SER genes.
However, for only SER33, and not SER3, expression was regulated
in relation to the available nitrogen source in a coordinated
fashion with SER1 and SER2. Based on these mRNA data together
with data on enzyme activities, Ser33p is likely to be the main
isoenzyme of the phosphoglycerate pathway during growth on glucose.
Moreover, since phosphoglycerate dehydrogenase activity requires NAD+
as cofactor, deletion of SER3 and SER33 markedly affected redox
metabolism as shown by substrate and product analysis.
| |
INTRODUCTION |
|---|
Amino acid biosynthesis may proceed via different metabolic routes in Saccharomyces cerevisiae. For instance, glycine can potentially be formed from threonine via threonine aldolase, Gly1p (Fig. 1). This pathway, the "threonine pathway," has been suggested to be the main glycine source on glucose media (1), but this function has not been verified. If glycine is formed, serine can subsequently be produced by interconversion of serine by tetrahydrofolate (THF) -dependent serine hydroxymethyltransferases, Shm1p and Shm2p (2-4). Alternatively, serine and glycine can be formed from glyoxylate, via the "glyoxylate pathway." However, since both the formation of glyoxylate and the alanine glyoxylate aminotransferase (encoded by YFL030W) needed for this biosynthetic pathway is glucose-repressed, this alternative route for the production of serine and glycine can only be employed in the absence of glucose (5-8). However, a third alternative is to start biosynthesis of serine and glycine from the glycolytic intermediate 3-phosphoglycerate (Fig. 1). The first reaction in this pathway, the "phosphoglycerate pathway," is catalyzed by phosphoglycerate dehydrogenase (EC 1.1.1.95), producing 3-phosphohydroxypyruvate plus NADH from 3-phosphoglycerate and NAD+. The enzymes of the subsequent two reactions are phosphoserine transaminase (Ser1p, EC 2.6.1.52) and phosphoserine phosphatase (Ser2p, EC 3.1.3.3). Deletion mutants of either SER1 or SER2 need an external source of serine during growth on glucose (5, 6, 9). However, genes encoding the first enzyme of the pathway, phosphoglycerate dehydrogenase, have as yet not been identified in S. cerevisiae.
Based on sequence similarity (47% identity) to the phosphoglycerate dehydrogenase gene in Escherichia coli we have previously suggested that yeast has two putative phosphoglycerate dehydrogenases (10). Those genes, YER081W and YIL074C, encode proteins that are 92% identical to each other. They are here denoted SER3 and SER33, respectively. Sequence similarity analysis of available phosphoglycerate dehydrogenases revealed two groups of proteins; S. cerevisiae and E. coli enzymes representing one group and rat liver and B. subtilis enzymes representing the other (11). The E. coli and yeast enzymes also have in common their preference for the co-substrate NAD+ instead of NADP+ (5, 12).
Furthermore, Zhao and Winkler (12) have shown that the E. coli enzyme has hydroxyglutarate dehydrogenase activity (EC 1.1.99.2) in addition to phosphoglycerate dehydrogenase activity, whereas this was not the case for the rat liver enzyme (11). Based on the above similarities we have recently suggested that the yeast enzyme may exert dual activities (10). In S. cerevisiae, we showed 2-hydroxyglutarate to be formed from glutamate, probably via the tricarboxylic acid cycle intermediate 2-oxoglutarate, when glutamate served as the sole nitrogen source (10). However, hydroxyglutarate dehydrogenase activity has as yet not been reported in yeast.
Other proteins with homology to Ser3/33p may also be candidates for having hydroxyglutarate dehydrogenase activity in S. cerevisiae: (i) Ypl113cp (27% identity), (ii) Ygl185cp (21-23% identity), with similarities to hydroxyacid dehydrogenases, (iii) Fdh1p (26-27% identity), a formate dehydrogenase, and (iv) Ynl274cp (25-26% identity), which is a putative hydroxyisocaproate dehydrogenase (13).
In the present study, we have investigated physiological and expression
properties of yeast strains with single and double deletions of
SER3 and SER33. Our data establish that SER3 and
SER33 encode phosphoglycerate dehydrogenases and that they appear
to be the only enzymes with such activity in S. cerevisiae. Ser33p
seems to be the main isoenzyme of the phosphoglycerate pathway
of serine/glycine biosynthesis.
| |
EXPERIMENTAL PROCEDURES |
|---|
Strains, Media, and Growth Conditions-- We have used the
S. cerevisiae strain, CEN.PK113-7D (MATa SUC2 GAL MAL2-8c)
as the protoptrophic wild type (14). Mutant strains of
YER081W and YIL074C genes, YVL87 and YVL88, were obtained
from the isogenic strains CEN.PK111-32D (MATa
leu2-3,112 SUC2 GAL MAL2-8c) and CEN.PK110-10C (MAT
his3
1
SUC2 GAL MAL2-8c), respectively. All the CEN.PK strains mentioned
can be received from EUROSCARF, Frankfurt, Germany
(www.uni-frankfurt.de/fb15/mikro/EUROSCARF/).
YPD, containing 10 g/liter of yeast extract, 20 g/liter of peptone, 20 g/liter of glucose, was used as complex medium. Agar (20 g/liter) plates were prepared from either YPD or, when defined conditions was needed, from YNB (1.7 g/liter of yeast nitrogen base without amino acids and ammonium sulfate, Difco), with appropriate additions of carbon and nitrogen sources as well as supplements. Sporulation medium contained 10 g/liter of potassium acetate and 20 g/liter of agar.
For liquid cultures, a synthetic defined medium was used, CBS (15), with glucose as carbon and energy source at a concentration of 20 g/liter and glutamate (3.5 g/liter) or ammonium sulfate (5 g/liter) as the nitrogen source. When needed, glycine (0.5 g/liter) or serine (0.7 g/liter) was added. The initial pH of the medium was adjusted to 6.0.
Inoculum cultures were grown on synthetic defined medium with glucose and were supplemented with serine. Cultures were grown in Erlenmeyer flasks (E-flasks) at 30 °C (the volume of flask was twice the volume of medium) on a rotary shaker resulting in semi-aerobic conditions and inoculated with 1.7% of the total culture volume.
Gene Disruptions-- Each open reading frame (ORF)1 was substituted with a deletion cassette containing either the HIS3 gene (to replace ORF YIL074C) or the LEU2 gene (to replace ORF YER081C). Deletion cassettes were prepared with 2 rounds of PCR according to Wach (16) from the plasmids YDp-H and YDp-L, respectively (17), using the following oligonucleotides (5' to 3', the sequence complementary to YDp plasmids is underlined). For ORF YER081W: L1, ACTCACAATCGAGTAATGCC; L2, GCTCAATCAATCACCGGATCCCCGGAATGCTTGTCATTGCTGTCG; L3, GCTCAATCAATCACCGGATCCGTCGCCTCTGCTAAGATCTCAATT; L4, AATTCCATCGGTTCAGTGGA. For ORF YIL074C: L1, AGGCTTGCAGGAGCAATTGT; L2, GCTCAATCAATCACCGGATCCCCGGTCGGCAGCTGAATAAGACAT; L3, GCTCAATCAATCACCGGATCCGTCGGCCAAAGTTTCCATCAGGTT; L4, CAGTTCATTCGAGATCTCAG. PCR reactions were performed as follows: (i) first round with Taq DNA polymerase (Fermentas), 2 min at 94 °C and 30 cycles of [30 s at 94 °C, 30 s at 50 °C, 1 min at 72 °C], and (ii) second round with the Expand Long Template PCR System (Roche Molecular Biochemicals), 1 min at 94 °C and 30 cycles of [15 s at 94 °C, 30 s at 45 °C, 1.5 min at 68 °C]. A final elongation step of 10 min was performed at the end of both rounds. Deletion cassettes were then purified using the QIAquick Gel Extraction kit (Qiagen) and introduced in yeast cells according to Ito et al. (18).
For gene disruption, cells were routinely grown at 30 °C on YPD plates. Deletion mutants were selected on YNB-HIS or YNB-LEU plates (6.7 g/liter of a yeast nitrogen base with ammonium sulfate but without amino acids, with addition of 0.77 g/liter CSM-HIS or 0.69 g/liter CSM-LEU (BIO101), respectively). Correct integration of the replacement cassettes was confirmed by PCR on genomic DNA (19) using primers L1 and L4, and restriction analysis of the amplified fragment. Six individual clones were tested for each disruption.
Double mutants were obtained by mating and subsequent tetrad analysis of the
strains YVL87 (MATa yer081w::LEU2) and YVL88 (MAT
yil074c::HIS3). Genomic DNA from 20 segregants (5 tetrads) was
prepared, and the presence of both replacement cassettes was verified
by PCR and enzymatic restriction. No defects in mutant mating or in
sporulation efficiency were observed.
Growth and Metabolite Analyses-- Biomass concentration was determined from dry weight and optical density measurements at 610 nm (OD610). Growth curves were performed by measurements of the OD610 in E-flask cultures or in microtiter plates in 350-µl cultures (BioScreen, Labsystems) by measurement of the turbidity during 36 h (OD measurements over 20 min). The turbidity was recalculated to true OD using a calibration curve earlier determined (20) to compensate for the non-linear OD measurements at higher cell densities. From these curves the maximal specific growth rate was determined.
Growth tests were performed on YNB plates, with a carbon source (20 g/liter of glucose or ethanol), a main nitrogen source (5 g/liter of ammonium, 3.5 g/liter of glutamate, or 10 g/liter glycine or threonine), and eventually an additional nitrogen source (120 mg/liter serine, glycine, or threonine). Inocula were grown in liquid YPD. Cells were washed in the corresponding YNB medium and diluted to an OD610 of 1. Aliquots of 10 µl of serial one-tenth dilutions (undiluted and 5 subsequent dilutions) were dropped on plates with appropriate medium and incubated for 2 days (ethanol plates for 6 days) at 30 °C.
Product formation and substrate consumption of the entire respiro-fermentative growth phase were determined from medium samples taken at inoculation and directly after glucose exhaustion. Glucose depletion was checked using Diabur-Test® 5000 test-strips (Roche). Extracellular concentrations of metabolites (including glucose) were measured with HPLC (Waters) using an ion-exchange column, HPX-87H, BioRad, as described previously (10). Glutamic acid concentration was determined using an enzymatic kit assay (Roche Molecular Biochemicals). Glycine was determined by measurements of the total free amino acid nitrogen concentration, by staining with ninhydrin (21), from which the glutamic acid contribution was subtracted. The standard solution contained both glutamate and glycine in the same concentration ranges as present in the experiments.
Northern Blot Analyses-- Gene expression was investigated in cells
grown in CBS medium supplemented with glucose as carbon source, and glutamate (± serine,
threonine, or glycine) or ammonium as nitrogen source. Cells were
grown at 30 °C, and RNA was extracted from cells during
respiro-fermentative exponential growth to the diauxic shift. Total
RNA was isolated from yeast cells as described by Ausubel et al.
(19) using a FastPrep apparatus (BIO101). RNA samples
(10 µg per lane) were fractionated on 1% agarose gels containing
formaldehyde, transferred by downward capillary blotting onto
Hybond-N+ membranes (Amersham
Biosciences) in 10× SSC (22) and cross-linked
using a GS GeneLinker (BioRad). Blots were then prehybridized at
65 °C for at least 2 h in 5× SSC, 50 mM NaH2PO4
(from a 1 M stock solution at pH 6.5), 5×
Denhardt's solution, 0.5% SDS, and 0.1 mg/ml denatured salmon sperm
DNA, and then hybridized at 65 °C for 16 h with a 32P-labeled
probe. The mRNA encoding the inorganic pyrophosphatase, IPP1,
was selected as reference. SER1, SER2, YNL274C, YPL113C,
YGL185C, FDH1, and IPP1 probes were prepared from the
following PCR fragments (5' to 3'). The resulting fragment length is
given in parenthesis. SER1 (1110 bp): TTGGAAAGAGAGGAACCACAACA
and ATAGATGGAGGCTCTGAACCCAC. SER2 (868 bp):
GTTATCACCTGCATAGCTCATGGAG and TGTCAGTCATGCTCTTGGTATTCAA. YNL274C
(950 bp): TGTTTTGAAATTAGGAAAGGATGCC and TCTTTGCATTTTCAACGACCAGT.
YPL113C (1107 bp): TGGTGCCTTATAAAACCCAATGG and CCTCGACAAATATGTCCTGCACA.
YGL185C (1106 bp): ATGTGCGATTCTCCTGCAACGAC and
GCTTCCCCAGACACTACCCGTAA. FDH1 (1104 bp):
ATGTCGAAGGGAAAGGTTTTGCT and GGCATAAGAACCATTCTGCACAATA. IPP1
(830 bp): AGACAAATTGGTGCCAAGAA and AAGAACCACTTGTCAATAGAC. These were
labeled with [
-32P]dCTP
(3000 Ci/ml) by use of a Megaprime DNA labeling kit (Amersham
Biosciences) and purified on a Nick column (Amersham
Biosciences). SER3 and SER33 probes were prepared from
the following oligonucleotides (5' to 3', 24 nucleotides). SER3;
TAAGTTGTTAATGTCAATGCTTGT and ACAGCATTCAAGCGCTGTGGAACG. SER33;
TAAATTATCGGCAGCTGAATAAGA and GTAATGCTTACACGACGAGGTAGT. These were
labeled with [
-32P]ATP
(3000 Ci/ml) by use of the T4 polynucleotide kinase (MBI) and
purified on a microspin G25 column (Amersham
Biosciences). The specificities of the oligonucleotides used for
probing SER3 and SER33 mRNA were controlled using the
ser3
,
ser33
,
and ser3
ser33
strains. Blots were washed 2× 5 min at room temperature and 2× 5 min
at 65 °C in 0.5× SSC/0.1% SDS, then exposed 6-24 h to PhosphorImager
screens. Non-saturated signals were measured by a BioRad FX
PhosphoImager and quantified by densitometry. Values were normalized
by comparison with IPP1 signals.
Protein Expression Analysis-- For labeling of proteins, duplicate
cultures were inoculated from overnight cultures giving a starting OD610
of 0.07 and grown to an OD610 of 0.35-0.39 in
glucose/glutamate medium supplemented with glycine. A volume of 1 ml
was transferred to a separate flask (10 ml) and 8 µl (3.2 MBq) of
L-[35S]methionine (specific activity >37
TBq/mmol, Amersham
Biosciences) was added. The cultures were grown for another 30 min
and then placed on ice. Cells were harvested (15,000 × g,
4 °C, 5 min), washed once with ice-cold milliQ water (Millipore), and
the resulting cell pellet was stored at
80 °C
until used. Proteins were extracted, the amount of incorporated
35S was measured and proteins (in 2,000,000 dpm of extract) were
separated by two-dimensional PAGE (23). The protein
pattern was detected by phosphorimaging and protein quantification
was performed by image analysis with the PDQUEST software (BioRad).
At least 2-fold and statistically significant changes (Student's
t test on log-transformed data) in protein levels were
distinguished. Resolved proteins have previously been identified by
microsequencing or MALDI-MS (23, 24).
Protein identity data can be found at yeast-2DPAGE.gmm.gu.se.
Crude Cell Extract Preparation and Enzyme Activity Measurements--
Crude cell extracts were prepared from 50 ml of culture. Cells were harvested
(2,000 × g, 4 °C, 5 min) and washed twice (20 and 1 ml) with
washing buffer (10 mM KH2PO4, pH
7.5, containing 2 mM EDTA). The sedimented
cell pellet was frozen in liquid nitrogen and stored at
20 °C
until further treatments. The thawed cell pellet was resuspended in
1 ml of extraction buffer (2 mM MgCl2
and 1 mM dithiothreitol in 100 mM
KH2PO4, pH 7.5) and supplemented with protease
inhibitors (1 µl of 35 g/liter phenylmethylsulfonylfluoride in
ethanol and 0.6 µl of 0.8 g/liter pepstatin and 1.2 g/liter leupeptin
in ethanol). Cells were disrupted by vortexing with 1 g of glass
beads (diameter 0.5 mm) for 5 min at 4 °C. The suspension was then
transferred to a 1.5-ml tube, and the beads were washed with 0.5 ml
of extraction buffer (supplemented with appropriate amounts of
protease inhibitors). After centrifugation at 15,000 × g,
4 °C, 15 min (if necessary twice), pooled supernatants were used
immediately for measurement of enzyme activity and protein content.
For preparation of crude extracts used in analysis of phosphoserine
phosphatase (Ser2p) activity (see below), Tris-HCl buffer at the same
concentration and pH was used instead of the ordinary phosphate
buffer.
Enzyme activities (except for Ser2p activity) and protein content were measured at 30 °C on a COBAS Fara Autoanalyser (Roche Molecular Biochemicals). Protein concentration was determined according to Lowry et al. (25), with bovine serum albumin as standard.
Phosphoglycerate dehydrogenase (EC 1.1.1.95) activity was measured by reduction of hydroxypyruvate phosphate, following the decrease of NADH at 340 nm. The reaction mixture contained 1 mM dithiothreitol, 0.25 mM NADH, 400 mM KCl, and 0.36 mM hydroxypyruvate phosphate (prepared from the corresponding dimethylketal, Sigma) in 40 mM KH2PO4 buffer, pH 7.5.
For measurements of phosphoserine transaminase activity the assay of Hirsch-Kolb and Greenberg was essentially used (26), following the decrease of NADH. The reaction mixture contained 4 mM NaF, 0.25 mM NADH, 30 mM ammonium acetate, 20 µM pyridoxal phosphate, 10 units/ml of glutamate dehydrogenase (NAD(P)-dependent, type III bovine liver, Sigma), 8 mM Na-L-glutamate, and 0.36 mM hydroxypyruvate phosphate in 50 mM Tris-HCl buffer, pH 8.2.
Phosphoserine phosphatase was determined manually at 30 °C with crude extracts in a reagent solution containing 5 mM O-phospho-L-serine and 5 mM MgCl2 in 65 mM Tris-HCl buffer, pH 7.5. The reaction was stopped in aliquots of reaction mixture (320 µl) with 80 µl of trichloroacetic acid (250 g/liter) at appropriate time intervals after extract addition (up to 10 min). Subsequent determination of released phosphate was performed according to Dryer et al. (27). There was no background release of phosphate in the reagent solution during the time of measurement, thus giving the enzymatic activity directly from the rate of phosphate release.
Hydroxyglutarate dehydrogenase (EC 1.1.99.2) activity was measured by reduction of 2-oxoglutarate, following the decrease of NADH. The reaction mixture contained 1 mM dithiothreitol, 0.25 mM NADH, and 5 mM 2-oxoglutarate in 40 mM KH2PO4 buffer, pH 7.5. Formation of 2-hydroxyglutarate during assay condition was checked by HPLC. Glutamate dehydrogenase activity was shown to negligibly contribute to the reduction of NADH in the hydroxyglutarate dehydrogenase assay, despite the fact that the crude extracts contained small amounts of ammonium.
Activity of hydroxyisocaproate dehydrogenase was measured in the same way as the hydroxyglutarate dehydrogenase, except that 6 mM of 2-oxoisocaproate was used as substrate.
Enzyme activity (units, µmol/min) was determined from the difference in slope
of NADH absorbance (at 340 nm,
= 6.3 mM
1
cm
1)
after and before addition of substrate (3-phosphohydroxypyruvate,
3-phosphohydroxypyruvate plus glutamate, 2-oxoglutarate, or 2-oxoisocaproate).
When the slope prior to substrate addition was equal to or larger
than the slope after substrate addition, then the detection limit
was estimated as follows. The variances of the two slopes obtained
in the linear regression of absorbance data were added and the
95% confidence interval was calculated according to a t-distribution.
The detection limit was around 0.2 units/g of protein for the
phosphoglycerate dehydrogenase and between 0.1-0.6 units/g of protein
for the hydroxyisocaproate dehydrogenase.
| |
RESULTS |
|---|
Ser3p and Ser33p Are Phosphoglycerate Dehydrogenases in S. cerevisiae-- The full-length coding sequences of SER3 (YER081W) and SER33 (YIL074C) were deleted and replaced with LEU2 and HIS3 markers, respectively, in the haploid strains CEN.PK111-32D and CEN.PK110-10C, respectively. This yielded isogenic strains without auxotrophic markers. A haploid double deletion mutant was obtained by mating and subsequent sporulation. The single and double deletion mutants were viable and formed colonies of normal size and morphology on complex media.
During growth on glucose, deletion mutants of all functional phosphoglycerate
dehydrogenases should result in a block in the phosphoglycerate
pathway of serine/glycine biosynthesis. Such mutants would require
externally available serine or glycine, provided that no alternative
pathways are active, such as the glyoxylate or threonine pathways
(Fig. 1). As shown in Fig. 2A,
the SER3 and SER33 genes encode the only functional
phosphoglycerate dehydrogenases since the double mutant required
serine for growth, while the single ser3
and ser33
mutants could grow in the absence of serine. Furthermore, the
glyoxylate pathway provides no alternative during growth on glucose
since it is glucose-repressed (5-8). In contrast,
as expected the ser3
ser33
mutant grew well on ethanol as the only carbon source with ammonium
as the only nitrogen source (Fig. 2B).
|
|
In addition, the double deletion mutant (ser3
ser33
)
provides an opportunity to investigate the function of the second alternative
pathway, the threonine pathway, which has been suggested to be
important during growth on glucose (1). However, addition of
threonine did not allow growth of the double mutant, either when
added to ammonium (data not shown) or glutamate (Fig. 2C)
as the main nitrogen sources or when used as the sole nitrogen source
(data not shown). Thus, the threonine pathway seems to be non-functional
during all conditions tested.
Surprisingly, the addition of glycine to ammonium-containing medium did not support growth of the double mutant (Fig. 2A). However, ammonium mediates strong nitrogen catabolite repression on for example uptake systems (28). We therefore tested other nitrogen sources (Fig. 2C). The double mutant could grow on both glycine (or serine; data not shown)-supplemented glutamate medium or on glycine as the sole nitrogen source (data not shown). Both single deletion mutants could grow also on glutamate as sole nitrogen source (Fig. 2C).
We have measured enzymatic activities in crude extracts to confirm the
function of Ser3p and Ser33p as phosphoglycerate dehydrogenases
(Table I). The activity of the phosphoglycerate dehydrogenase
in Escherichia coli is inhibited by serine and to a lesser extent
by glycine (12, 29,
30). Since inhibition by serine has been reported also for yeast
(5), glycine was used as a supplementing nitrogen
source to glutamate in the following experiments in order to minimize
inhibition of phosphoglycerate dehydrogenase while still allowing
growth on glucose of the ser3
ser33
double mutant. The ser3
ser33
mutant showed no phosphoglycerate dehydrogenase activity (Table
I), indicating that only these two genes encode
such an activity. The specific activity determined in the wild-type
strain was equivalent to the sum of the activities found in the
single mutants. The reduction of phosphoglycerate dehydrogenase
activity was more pronounced in the ser33
mutant, indicating that Ser33p is the major isoenzyme. As may be
expected, since externally accessible glycine reduces the need for
its biosynthesis, addition of glycine reduced the activity in all
strains tested, most prominently in the ser33
mutant. Externally available glycine may affect the expression of the
SER3 and SER33 genes or modulate the activity of Ser3p
and Ser33p directly. To clarify the situation, the mRNA expression
was studied during growth with different nitrogen sources, see below.
Also when glycine was added to the medium, the activities measured in
the single mutants added up to that of the wild-type strain.
Expression of the SER Genes and Enzyme Activities during
Respiro-fermentative Growth-- The expression of genes encoding the enzymes
of the serine/glycine pathway was analyzed by Northern blot analysis during
respiro-fermentative growth and at the transition to respiratory
growth. Small but significant differences in gene expression between
the wild-type strain and the single mutants were observed (Fig.
3, A and B). The SER1, 2,
and 33 genes showed a declining expression during late
exponential growth. After glucose exhaustion, the mRNA level of
SER1 seemingly increased. However, this apparent increase of
SER1 mRNA probably results from the normalization of mRNA levels
with IPP1 expression. IPP1 seemed to be down-regulated at the
diauxic shift, since despite that the same amount (concentration
was measured) of total mRNA was loaded on the gels the amount
of IPP1 mRNA at this growth phase was low for all strains and
irrespective of type of nitrogen source (Fig. 3B; data
not shown). The low enzymatic activity of Ser1p determined at diauxic
shift also indicates a true low expression of SER1. However,
down-regulation of IPP1 has not been seen in recently reported
microarray studies (31). SER3 expression
was not affected by the deletion of SER33, whereas SER33
expression was slightly decreased in the ser3
mutant.
|
The enzyme activities of the three reactions of the pathway (Ser1p, Ser2p, Ser3/33p) were also analyzed to reveal correlations between gene expression and protein activity (Fig. 3, A versus C). The phosphoserine transaminase activity stayed constant during the respiro-fermentative growth phase but strongly decreased after glucose depletion. The phosphoserine phosphatase activity behaved similarly, although decreased already before glucose exhaustion. The specific activity of phosphoglycerate dehydrogenase first increased monotonically until glucose depletion and then decreased drastically at the diauxic shift. The SER enzyme activities followed the mRNA expression in that both decreased during the shift from respiro-fermentative to respiratory growth. Hence, the activity of the phosphoglycerate pathway seemed to some extent be regulated at the level of gene expression. Down-regulated activities of enzymes in the phosphoglycerate pathway at glucose exhaustion is expected because of relief of glucose-repression and is in agreement with that the glyoxylate pathway contributes significantly to serine/glycine formation at growth on ethanol.
Expression of SER Genes during Growth on Different Nitrogen Sources--
Since glycine addition was found to have an impact on the phosphoglycerate
dehydrogenase activity, the effect of different nitrogen sources on
the expression of the SER genes was then investigated. The
expression of all SER genes, except for SER3, was affected
by the nitrogen source in a similar way (Fig. 4). The
SER3 mRNA level was very sensitive to additions of serine,
glycine, and threonine, which largely reduced the expression, while
the expression of the other SER genes was only sensitive to
threonine addition (Fig. 4). Hence, the reduced
activities found in glycine-supplemented medium (Table
I) may partly be explained by reduced expression of SER3.
|
Although there was a tendency of decreased expression of the SER1, SER2, and SER33 genes in the mid-exponential phase during growth on ammonium as compared with glutamate, this difference was not statistically significant. However, a consistently lower enzymatic activity of phosphoglycerate dehydrogenase (0.99 units/g of protein) was measured in the wild-type strain when ammonium was used as the sole nitrogen source (data not shown). This observed activity is similar to that reported previously (1.1-1.5 units/g of protein) for growth on ammonium (6).
Consequences of Growth and Metabolism When Deleting the SER3/33 Genes--
In order to determine consequences of SER3 and SER33 deletions on
growth and metabolism, we first determined the maximal specific
growth rates (Table II). Cells were grown on microtiter
plates in liquid medium, with and without additional glycine, in the
presence of glucose as carbon source and glutamate as main nitrogen
source. The wild-type strain grew only slightly faster than both
single mutants. Addition of glycine reduced the growth rate of
both the wild-type strain and the single mutants about 15%. The
double mutant, which was able to grow when glycine was supplemented,
showed the slowest growth rate of all strains (85% of the wild-type
level). The growth rate of the ser3
ser33
mutant was not reduced because the interconversion of glycine to
serine was rate-limiting, since the maximal specific growth rate of
the wild type remained the same in the presence of both serine and
glycine (data not shown).
|
The metabolite product pattern during the entire period of respiro-fermentative growth was also monitored. The strains were grown on medium with glutamate as nitrogen source, without and with glycine; to fulfill the auxotrophic requirement of the double deletion mutant (Table III).
|
With glutamate as the sole nitrogen source, deletion of either SER3 or
SER33 only slightly affected the production of biomass and of
major end products of growth (ethanol and glycerol) compared with
that of the wild type (Table III). On the other hand, acetic
acid production decreased in the mutants, which was balanced with
a substantial increase in pyruvic acid production. Despite the
fact that glutamate was consumed in similar amounts, two products of
its metabolism, succinic and 2-hydroxyglutaric acids, were formed in
lower amounts in both single mutants, while this reduction was to
some extent balanced with a slightly increased production of its
first conversion product, 2-oxoglutarate and of fumaric acid. The
recorded changes in metabolite production in both single mutants,
indicate an altered flux distribution to and within the tricarboxylic
acid cycle in ser3
and ser33
mutants compared with the wild type during growth on glutamate as
sole nitrogen source. In total, there were small differences between
the ser3
and ser33
mutants grown on glutamate as the sole nitrogen source.
Glycine supplementation influenced largely the pattern of formed metabolites in all strains (Table III). The addition of glycine to the medium resulted in a diminished consumption of glutamate, while the total amount of nitrogen taken up was similar for all strains with and without glycine supplementation (0.80-0.83 mmol of nitrogen/g of glucose).
There were many indications of an altered metabolism during growth on glutamate plus glycine when both SER3 and SER33 was deleted as compared with the wild type (Table III). Thus, in the double mutant the amounts of ethanol, glycerol, 2-oxoglutaric acid, 2-hydroxyglutaric acid, and fumaric acid formed decreased, while the amounts of acetic acid and succinic acid increased. Formation of 2-hydroxyglutaric acid was not even detectable in the double mutant (Table III). All these altered levels indicate a changed redox metabolism in the double deletion mutant as compared with the wild-type strain.
In order to determine if effects of SER3 and SER33 deletions on metabolism could be explained by altered expression levels of cellular proteins, two-dimensional PAGE analysis was performed with protein extracts of the wild type and the double mutant from samples taken in mid-exponential growth phase in glutamate plus glycine medium. However, very few and only minor changes were observed when about 500 proteins were analyzed (data not shown). All recorded expression changes corresponded to unidentified proteins except for Tdh1p. This minor isoform of glyceraldehyde-3-phosphate dehydrogenase was up-regulated 3-fold in the double mutant (from 325 ± 11 ppm in the wild-type strain to 974 ± 75 ppm in the double mutant, with the maximal deviation given). Interestingly, Shm2p, one of the serine/glycine-interconverting serine hydroxymethyltransferases, was present in similar amounts in both strains. Hence, the difference in metabolite levels were not due to an altered amount of proteins. Possible spots in the two-dimensional PAGE gels for Ser3p and Ser33p, which were absent for the double mutant, were found at a molecular mass of 50 kDa and pI of 5.6 and 6.2, respectively, close to their theoretical values (5.39 and 6.18). However, further identification is required.
Other Functions of the SER3/33 Genes-- In bacteria, the formation of 2-hydroxyglutarate from 2-oxoglutarate is dependent on the presence of a hydroxyglutarate dehydrogenase activity (12, 32). Indeed, hydroxyglutarate dehydrogenase activity was also present in crude extracts of S. cerevisiae (Table IV). The activity was highly dependent on NADH as cofactor. Use of NADPH as cofactor in the activity assay yielded only 15-20% of the activity as measured with NADH (data not shown). The specific hydroxyglutarate dehydrogenase activity increased about 4-fold during respiro-fermentative growth for both the wild-type strain (Fig. 5) and all mutants (data not shown).
|
|
Since the E. coli phosphoglycerate dehydrogenase has a
hydroxyglutarate dehydrogenase activity, candidates for yeast enzymes
with such activity were Ser3p and Ser33p, as well as their homologues,
Ynl274cp, Ygl185cp, Ypl113cp, and Fdh1p. However, absence of Ser33p,
or of both Ser3p and Ser33p, rather resulted in a higher hydroxyglutarate
dehydrogenase activity (Table IV). On the other hand,
the ser3
ser33
mutant did not form any 2-hydroxyglutarate in glutamate/glycine
medium (Table III) but traces of this metabolite were found
during anaerobic growth in glutamate/serine medium (data not
shown).
One of the candidates for hydroxyglutarate dehydrogenase activity, Ynl274cp,
has been assigned a hydroxyisocaproate dehydrogenase activity (13).
The activity of hydroxyisocaproate dehydrogenase increased during
respiro-fermentative growth and reached a value of 1-5 units/g of
protein at the diauxic shift in both wild-type and mutants strains
(Fig. 5B and data not shown), which was in
accordance with the range reported previously (13) for a
wild-type strain growing in ethanol medium (2.3-5.9 units/g of
protein). The Northern blot analysis (Fig. 5B)
confirmed that expression of YNL274C is glucose-repressed (33).
Also expression of both YGL185C and YPL113C was
strongly diminished in glucose medium (Fig. 5C),
and the mRNA of the FDH1 could not be detected. No clear
difference in expression of the homologues was seen comparing the
ser3/33 mutants with the wild type (data not shown).
| |
DISCUSSION |
|---|
Phosphoglycerate Dehydrogenase Activity-- We have in this work
demonstrated that the gene products of YER081W and YIL074C (in
this study renamed SER3 and SER33, respectively) both
have phosphoglycerate dehydrogenase activity. The double deletion
mutant, ser3
ser33
,
is auxotrophic for serine and glycine during growth on glucose.
Furthermore, phosphoglycerate dehydrogenase activity was absent in
crude extracts of the double mutant and lowered in single deletion
mutants. Consequently, Ser3p and Ser33p appear to be the only enzymes
with phosphoglycerate dehydrogenase activity present in
S. cerevisiae. In addition, the previously suggested pathway for
formation of glycine from threonine (1), the
threonine pathway, could not be confirmed. Even if threonine addition
reduced the expression of all SER genes, the ser3
ser33
mutant could neither grow on threonine as sole nitrogen source
nor as supplement to glutamate or ammonium. Hence, the main pathway
during growth on glucose for both serine and glycine biosynthesis
seems to be via Ser3p and Ser33p, i.e. by the phosphoglycerate
pathway.
In contrast, our data support the existence of a glucose-repressed pathway
from glyoxylate to serine and glycine (5-8), because
the ser3
ser33
double mutant could grow on ethanol as the sole carbon source in
absence of glycine and serine. Consistently, the mRNA expression of
all genes in the phosphoglycerate pathway (SER1, SER2,
SER3, and SER33) was diminished after glucose depletion,
and the corresponding specific enzyme activities were reduced
accordingly.
Deletion of either of the SER3/33 genes did only slightly affect
expression of its isogene and the sum of the specific activities in
the single ser3
and ser33
mutants equals that of the wild-type strain. Both isoenzymes are
needed for optimal growth, as illustrated by the slightly decreased
growth rates of both single mutants. On the other hand, given the
fact that Ser3p and Ser33p are 92% identical and that single deletion
only slightly affected growth, it appears that both proteins have
largely redundant functions in the cell under the conditions tested.
However, since Ser33p contributes to the major part of the enzymatic
activity and that expression of this gene appears to be perfectly
co-regulated with that of SER1 and SER2, Ser33p appears
as the main biosynthetic isoenzyme of the serine/glycine
pathway.
Metabolism on Different Nitrogen Sources-- Glycine added to ammonium
as main nitrogen source did not allow growth of the ser3
ser33
double mutant (Fig. 2), although this mutant needs
either serine or glycine for growth. Ammonium mediates a strong
repression on amino acid transport proteins. The main protein
involved in uptake of glycine is Gap1p (36), and
both protein function and production are repressed in the presence of
ammonium ions (37). Also glutamate decreases the
activity of Gap1p (38). The level of GAP1 expression
remains one fifth of that under derepressed conditions (37).
Also other proteins involved in glycine uptake, such as Agp1p, Tat2p,
Dip5, and Put4p, are all under nitrogen catabolite repression (39).
Thus, the effects of nitrogen repression on the uptake of glycine
provide a plausible explanation for the observed inhibited growth
when ammonium was accessible as the main nitrogen source. On the
other hand, the level of uptake mediated by Gap1p in presence
of glutamate was sufficient for growth of the double mutant when
glutamate was the main nitrogen source (Fig. 2). In addition
to effects on the uptake system, we cannot exclude the possibility
that ammonium ions repress components involved in the conversion
from glycine to serine, for example the serine hydroxymethyltransferases
(Fig. 1). Assimilation of glycine into serine is
catalyzed by the minor isoenzyme, the mitochondrial Shm1p, together
with the glycine cleavage system (3,
4).
Serine and glycine fulfill also a role as sources of one-carbon units (4).
The amounts of serine and glycine, as measured to be present in yeast
cells (15), corresponds to only 32% of the glycine
taken up by the cells (Table III). Thus, the residual
glycine taken up must be converted and is most probably used as
one-carbon units. It also seems, as the opposite is true, i.e.
that one-carbon units can serve as a source for serine and glycine
production since addition of exogenous one-carbon units (as formate,
10 mM) allowed slow growth of the double mutant on
ammonium salt as the nitrogen source (data not shown). A similar
observation has been reported for the ser1
mutant (3).
Addition of amino acids largely reduced the expression of SER3. Repression of SER3 mRNA by amino acids is consistent with that found in rich medium as compared with minimal medium (34). The promoter of the SER3 gene contains as many as 8 potential Gcn4p binding sites. Gcn4p is required for stimulated expression of genes encoding amino acid biosynthetic enzymes in response to amino acid starvation (35). Hence, amino acid depletion may stimulate expression of SER3 via the Gcn4p pathway.
Effects on Redox Metabolism-- Glycerol production is crucial during anaerobic conditions in order to reoxidize cytosolic NADH. The largest source of cytosolic net NADH production is amino acid synthesis for protein production (15, 40, 41). When glycine is added as an additional nitrogen source the need for synthesis of glycine and serine results in less NADH formation via the redox reaction catalyzed by Ser3/33p. The amount of serine and glycine in biomass (15) corresponds to about 15 mg of glycerol per g of glucose consumed in terms of redox equivalents (NADH). This is comparable to the decreased level of glycerol formation observed in the wild-type strain when glycine was added to the medium (Table III).
When glutamate is used as nitrogen source, its carbon skeleton is converted
to 2-oxoglutarate, succinate and 2-hydroxyglutarate, which appear as
extracellular products (10). This degradation
pathway is in accordance with our data. The ser3
ser33
double mutant consumed less glutamate than the wild-type strain. The
altered yield of degradation products calculated in the double
mutant (
0.068
mmol/g of glucose) fits with the observed reduced glutamate
consumption (
0.061
mmol/g of glucose), which has consequences on the redox metabolism.
The 2-oxoglutarate formed is a product of glutamate in transamination
reactions (10, 42, 43),
but no NADH formation is expected from these reactions. In contrast,
both the decreased 2-hydroxyglutarate and increased succinate
formation in the double mutant contribute to an increased production
of NADH (Fig. 1), which needs to be reoxidized. In addition,
acetate formation increased in the double mutant. Formation of
acetate from glucose is associated with formation of 1 or
2 NADH/acetate, depending on the use of NADP+- or NAD+-dependent
isoenzymes of aldehyde dehydrogenase (15, 44).
In addition, less glycerol was produced and consequently almost
all observed changes in metabolite formation in the double mutant
compared with the wild type resulted in increased cytosolic NADH
production. The amount of the minor isoenzyme of the glyceraldehyde
phosphate dehydrogenases in S. cerevisiae, Tdh1p seems to be
redox-regulated.2 Accordingly, the amount of Tdh1p
was increased in the ser3
ser33
double mutant indicating an increased cytosolic NADH/NAD+
ratio. However, since the cells were cultured under aerobic conditions,
the surplus of NADH formed, both cytosolically and/or in the mitochondria
(45, 46), should not create a redox
problem since it can still be reoxidized in the respiratory chain.
This is also reflected by a relatively non-affected growth rate of
the double mutant. In fact, the slightly increased biomass formation,
and the simultaneously decreased ethanol and glycerol production in
the double mutant as compared with the wild type, indicates an
increased oxidative metabolism in the former.
Hydroxyglutarate Dehydrogenase Activity-- Enzyme activity measurements
did not indicate that Ser3p or Ser33p might have the sought hydroxyglutarate
dehydrogenase activity, but still the ser3
ser33
double mutant formed only traces of 2-hydroxyglutarate. However, the
amount of 2-hydroxyglutarate found extracellularly reflects the
balance between formation and consumption. Hence, the ser3
and ser33
mutations may indirectly enhance the degradation of
2-hydroxyglutarate. We have previously found that yeast cells are
able to consume 2-hydroxyglutarate added to the medium (47),
but no degradation pathways have yet been suggested in the
literature. It appears that yet unidentified enzyme(s) are
responsible for 2-hydroxyglutarate formation during glucose growth,
since the alternative enzymes investigated in this study (Ynl274p,
Ypl113p, and Ygl185p) are all glucose-repressed.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Ellinor Pettersson for help with the two-dimensional PAGE gels and Dr. Thomas Andlid (Dept. Food Science, Chalmers University of Technology) for HPLC analysis and demonstrating that 2-hydroxyglutarate is formed by crude extracts.
| |
FOOTNOTES |
|---|
* This work was financially supported by the Swedish National Energy Administration (Energimyndigheten).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed. Tel.: 46-31-773-2598; Fax: 46-31-773-2599; E-mail: Eva.Albers@molbiotech.chalmers.se.
Present address: Universidade do Algarve, Centro de Cięncias do Mar, Campus de
Gambelas, P-8000-117 Faro, Portugal.
Published, JBC Papers in Press, January 13, 2003, DOI 10.1074/jbc.M211692200
2 H. Valadi, Ĺ. Valadi, J. Norbeck, R. Ansell, L. Gustafsson, and A. Blomberg, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: ORF, open reading frame; MALDI, matrix-assisted laser desorption; HPLC, high performance liquid chromatography.
| |
REFERENCES |
|---|
| 1. | Monschau, N., Stahmann, K.-P., Sahm, H., McNeil, J. B., and Bognar, A. L. (1997) FEMS Microbiol. Lett. 150, 55-60 |
| 2. | Sinclair, D. A., and Dawes, I. W. (1995) Genetics 140, 1213-1222 |
| 3. | McNeil, J. B., Bognar, A. L., and Pearlman, R. E. (1996) Genetics 142, 371-381 |
| 4. | Piper, M. D., Hong, S.-P., Ball, G. E., and Dawes, I. W. (2000) J. Biol. Chem. 275, 30987-30995 |
| 5. | Ulane, R., and Ogur, M. (1972) J. Bacteriol. 109, 34-43 |
| 6. | Melcher, K., and Entian, K.-D. (1992) Curr. Genet. 21, 295-300 |
| 7. | Melcher, K., Rose, M., Kunzler, M., Braus, G. H., and Entian, K.-D. (1995) Curr. Genet. 27, 501-508 |
| 8. | Takada, Y., and Noguchi, T. (1985) Biochem. J. 231, 157-163 |
| 9. | Belhumeur, P., Fortin, N., and Clark, M. W. (1994) Yeast 10, 385-389 |
| 10. | Albers, E., Gustafsson, L., Niklasson, C., and Lidén, G. (1998) Microbiology 144, 1683-1690 |
| 11. | Achouri, Y., Rider, M. H., van Schaftingen, E., and Robbi, M. (1997) Biochem. J. 323, 365-370 |
| 12. | Zhao, G., and Winkler, M. E. (1996) J. Bacteriol. 178, 232-239 |
| 13. | Dickinson, J. R., Lanterman, M. M., Danner, D. J., Pearson, B. M., Sanz, P., Harrison, S. J., and Hewlins, M. J. E. (1997) J. Biol. Chem. 272, 26871-26878 |
| 14. | Entian, K.-D., and Kötter, P. (1998) in Methods in Microbiology (Brown, A. J. P. , and Tuite, M., eds), Vol. 26 , pp. 431-449, Academic Press, London, UK |
| 15. | Albers, E., Larsson, C., Lidén, G., Niklasson, C., and Gustafsson, L. (1996) Appl. Environ. Microbiol. 62, 3187-3195 |
| 16. | Wach, A. (1996) Yeast 12, 259-265 |
| 17. | Berben, G., Dumont, J., Gilliquet, V., Bolle, P.-A., and Hilger, F. (1991) Yeast 7, 475-477 |
| 18. | Ito, H., Fukuda, Y., Murata, K., and Kimura, A. (1983) J. Bacteriol. 153, 163-168 |
| 19. | Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (eds) (1996) Current Protocols in Molecular Biology , John Wiley & Sons, New York |
| 20. | Warringer, J., and Blomberg, A. (2003) Yeast 20, 53-63 |
| 21. | European Brewery Convention. (1987) Analytica-EBC , 4th Ed. , pp. E141-E142, European Brewery Convention, Zurich |
| 22. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , pp. 7.1-7.87, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY |
| 23. | Norbeck, J., and Blomberg, A. (1997) Yeast 13, 1519-1534 |
| 24. | Larsson, T., Norbeck, J., Karlsson, H., Karlsson, K.-A., and Blomberg, A. (1997) Electrophoresis 18, 418-423 |
| 25. | Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275 |
| 26. | Hirsch-Kolb, H., and Greenberg, D. M. (1971) Methods Enzymol. 17B, 331-334 |
| 27. | Dryer, R. L., Tammes, A. R., and Routh, J. I. (1957) J. Biol. Chem. 225, 177-183 |
| 28. | ter Schure, E. G., van Riel, N. A. W., and Verrips, C. T. (2000) FEMS Microbiol. Rev. 24, 67-83 |
| 29. | Sugimoto, E., and Pizer, L. I. (1968) J. Biol. Chem. 243, 2081-2089 |
| 30. | Grant, G. A., Schuller, D. J., and Banaszak, L. J. (1996) Prot. Sci. 5, 34-41 |
| 31. | DeRisi, J. L., Lyer, W. R., and Brown, P. O. (1997) Science 278, 680-686 |
| 32. | Radler, F. (1986) Experientia 42, 884-893 |
| 33. | Planta, R. J., Brown, A. J., Cadahia, J. L., Cerdan, M. E., de Jonge, M., Gent, M. E., Hayes, A., Kolen, C. P., Lombardia, L. J., Sefton, M., Oliver, S. G., Thevelein, J., Tournu, H., van Delft, Y. J., Verbart, D. J., and Winderickx, J. (1999) Yeast 15, 329-350 |
| 34. | Sudarsanam, P., Iyer, V. R., Brown, P. O., and Winston, F. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 3364-3369 |
| 35. | Hinnebusch, A. G. (1988) Microbiol. Rev. 52, 248-273 |
| 36. | Grenson, M., Hou, C., and Crabeel, M. (1970) J. Bacteriol. 103, 770-777 |
| 37. | Soussi-Boudekou, S., and André, B. (1999) Mol. Microbiol. 31, 753-762 |
| 38. | Stanbrough, M., and Magasanik, B. (1995) J. Bacteriol. 177, 94-102 |
| 39. | Regenberg, B., Düring-Olsen, L., Kielland-Brandt, M. C., and Holmberg, S. (1999) Curr. Genet. 36, 317-328 |
| 40. | Oura, E. (1977) Proc. Biochem. 12, 19- 21, 35 |
| 41. | van Dijken, J. P., and Scheffers, W. A. (1986) FEMS Microbiol. Rev. 32, 199-224 |
| 42. | Lewis, M. J., and Rainbow, C. (1963) J. Inst. Brew. 69, 39-45 |
| 43. | Cooper, T. G. (1982) in The Molecular Biology of the Yeast Saccharomyces cerevisiae (Strathern, J. N. , Jones, E. W. , and Broach, J. R., eds) , pp. 39-99, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 44. | Albers, E., Lidén, G., Larsson, C., and Gustafsson, L. (1998) Recent Res. Dev. Microbiol. 2, 253-279 |
| 45. | Larsson, C., Pĺhlman, I.-L., Ansell, R., Rigoulet, M., Adler, L., and Gustafsson, L. (1998) Yeast 14, 347-357 |
| 46. | Bakker, B. M., Overkamp, K. M., van Maris, A. J. A., Kötter, P., Luttik, M. A. H., van Dijken, J. P., and Pronk, J. T. (2001) FEMS Microbiol. Rev. 25, 15-37 |
| 47. | Albers, E. (2000) Nitrogen and Redox Metabolism in Saccharomyces cerevisiae.Ph.D. thesis , Chalmers University of Technology, Göteborg, Sweden |
| 48. | Jones, E. W., and Fink, G. R. (1982) in The Molecular Biology of the Yeast Saccharomyces cerevisiae (Strathern, J. N. , Jones, E. W. , and Broach, J. R., eds) , pp. 181-299, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 49. | West, M. G., Horne, D. W., and Appling, D. R. (1996) Biochemistry 35, 3122-3132 |
© 2005
Transgalactic Ltd (manufacturer of Bioscreen C software) |
Privacy Statement | P.O. Box
1393, 00101 Helsinki, Finland,
Last modified: May 25, 2005
| ||||||